New Hope for Breast Cancer Prevention: The Promise of Femara

The video discusses the use of hormonal drugs in breast cancer treatment, focusing on tamoxifen and Femara. Tamoxifen is typically used for five years post-treatment to prevent recurrence, but its effectiveness diminishes over time. Femara, a newer drug, has shown promising results in the MA 17 international trial, which was concluded early due to its success in preventing cancer recurrence. Ongoing studies aim to determine how long Femara can effectively protect against breast cancer returning.

What was the outcome of the MA 17 international trial with Femara?

What is the potential benefit of Femara for women who have had breast cancer?